Vertex Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Microsoft, Berkshire Hathaway, Apple, Netflix, Palantir, Skechers: Biggest Movers
Here Are the Major Earnings After the Close Today
Vertex Pharmaceuticals: Promising Growth With Journavx Launch and Strong Pipeline Support Buy Rating
Earnings Scheduled For May 5, 2025
Vertex Pharmaceuticals Q1 2025 Earnings Preview
Notable Healthcare Headlines for the Week: Gilead, CVS Health, Sanofi in Focus
Earnings Week Ahead: AMD, PLTR, F, DIS, SHOP, DKNG, AMC, LCID, GOLD, RIVN, and More
Healthcare Sector Flexes Earnings Muscle, but Top-line Cracks Show
Gilead and Vertex Pharma Named Among Biotech's Tariff Safe Havens
Preview -- Barron's
Earnings Outlook For Vertex Pharmaceuticals
S&P Global, Berkshire Hathaway, CME Group And A Health Care Stock: CNBC's 'Final Trades'
Express News | CNBC Halftime Report Final Trades: Berkshire Hathaway - B Shares, Vertex Pharmaceuticals, S&P Global, CME Group
Earnings Preview: VRTX to Report Financial Results Post-market on May 05
$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
Vertex Pharmaceuticals Hits 4-week High
Citi Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating
Express News | The European Medicines Agency's Committee For Medicinal Products For Human Use Adopted A Positive Opinion For Vertex Pharmaceuticals' Alyftrek (Deutivacaftor/Tezacaftor/Vanzacaftor) For Cystic Fibrosis Patients Aged 6 Years And Older Who Have At Least...
Analysts Have Conflicting Sentiments on These Healthcare Companies: Pfizer (PFE), Vertex Pharmaceuticals (VRTX) and Erasca (ERAS)